Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-25T20:34:28.047Z Has data issue: false hasContentIssue false

Chapter 11 - Treatment

Published online by Cambridge University Press:  05 May 2016

Christopher M. Filley
Christopher M. Filley
Affiliation:
University of Colorado School of Medicine
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
White Matter Dementia , pp. 142 - 152
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akai, K, Uchigasaki, S, Tanaka, U, Komatsu, A. Normal pressure hydrocephalus: neuropathological study. Acta Pathol Jpn 1987; 37: 97–110.Google ScholarPubMed
Akiguchi, I, Ishii, M, Watanabe, Y, et al. Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol 2008; 255: 1392–1399.CrossRefGoogle ScholarPubMed
Alperin, N, Oliu, CJ, Bagci, AM, et al. Low-dose acetazolamide reverses periventricular white matter hyperintensities in NPH. Neurology 2014; 82: 1347–1351.CrossRefGoogle Scholar
Anderson, CA, Arciniegas, DB. Neurosurgical interventions for neuropsychiatric syndromes. Curr Psychiatry Rep 2004; 6: 355–363.CrossRefGoogle ScholarPubMed
Arciniegas, D, Adler, L, Topkoff, J, et al. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj 1999; 13: 1–13.CrossRefGoogle Scholar
Arciniegas, DB, Wortzel, HS, Frey, K. Rehabilitation and pharmacoptherapy of cognitive impairments. In: Arciniegas, DB, Anderson, CA, Filley, CM, eds. Behavioral neurology & neurospychiatry. Cambridge: Cambridge University Press, 2013: 511–542.CrossRefGoogle Scholar
Bartzokis, G, Lu, PH, Raven, EP, et al. Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia. Schizophr Res 2012; 140: 122–128.CrossRefGoogle ScholarPubMed
Biffi, A, Lucchini, G, Rovelli, A, Sessa, M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant 2008; 42 Suppl 2: S2–S6.CrossRefGoogle ScholarPubMed
Biotti, D, Esteban-Mader, M, Diot, E, et al. Clinical reasoning: a young woman with rapid mental deterioration and leukoencephalopathy. Neurology 2014; 83: e182–e186.CrossRefGoogle Scholar
Birks, J, Craig, D. Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev 2006; 4: CD004746.Google Scholar
Blasko, I, Hinterberger, M, Kemmler, G, et al. Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort. J Nutr Health Aging 2012; 16: 687–694.CrossRefGoogle ScholarPubMed
Boor, JW, Hurtig, HI. Persistent cerebellar ataxia after exposure to toluene. Ann Neurol 1977; 2: 440–442.CrossRefGoogle ScholarPubMed
Cairney, S, O’ Connor, N, Dingwall, KM, et al. A prospective study of neurocognitive changes 15 years after chronic inhalant abuse. Addiction 2013; 108: 1107–1114.CrossRefGoogle ScholarPubMed
Cardenas, VA, Meyerhoff, DJ, Studholme, C, et al. Evidence for ongoing brain injury in human immunodeficiency virus–positive patients treated with antiretroviral therapy. J Neurovirol 2009; 15: 324–333.CrossRefGoogle ScholarPubMed
Chatterjee, A, Yapundich, R, Palmer, CA, et al. Leukoencephalopathy associated with cobalamin deficiency. Neurology 1996; 46: 832–834.CrossRefGoogle ScholarPubMed
Cicerone, KD, Langenbahn, DM, Braden, C, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil 2011; 92: 519–530.CrossRefGoogle ScholarPubMed
Comi, G. Effects of disease modifying treatments on cognitive dysfunction in multiple sclerosis. Neurol Sci 2010; 31(Suppl 2): S261–S264.CrossRefGoogle ScholarPubMed
Del Bigio, MR. Neuropathological changes caused by hydrocephalus. Acta Neuropathol 1993; 85: 573–585.CrossRefGoogle ScholarPubMed
Del Bigio, MR, da Silva, MC, Drake, JM, Tuor, UI. Acute and chronic cerebral white matter damage in neonatal hydrocephalus. Can J Neurol Sci 1994; 21: 299–305.CrossRefGoogle ScholarPubMed
Demaerschalk, BM, Wingerchuk, DM. Treatment of vascular dementia and vascular cognitive impairment. Neurologist 2007; 13: 37–41.CrossRefGoogle ScholarPubMed
Deutsch, MB, Mendez, MF. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia. Cogn Behav Neurol 2015; 28: 1–10.CrossRefGoogle ScholarPubMed
Dubois, B, Slachevsky, A, Litvan, I, Pillon, B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621–1626.CrossRefGoogle ScholarPubMed
Ehrenstein, WH, Heister, G, Cohen, R. Trail Making Test and visual search. Arch Psychiatr Nervenkr 1982; 231: 333–338.CrossRefGoogle ScholarPubMed
Ellingson, BM, Cloughesy, TF, Lai, A, et al. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 2011; 13: 401–409.CrossRefGoogle ScholarPubMed
Filippi, CG, Sze, G, Farber, SJ, et al. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology 1998; 206: 491–498.CrossRefGoogle ScholarPubMed
Filley, CM. Toluene abuse and white matter: a model of toxic leukoencephalopathy. Psychiatr Clin North Am 2013; 36: 293–302.CrossRefGoogle Scholar
Filley, CM, Kleinschmidt-DeMasters, BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345: 425–432.CrossRefGoogle ScholarPubMed
Filley, CM, Kozora, E, Brown, MS, et al. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol 2009; 22: 38–44.CrossRefGoogle ScholarPubMed
Fischer, JS, Priore, RL, Jacobs, LD, et al. Neuropsychological effects of interferon β-1-a in relapsing multiple sclerosis. Ann Neurol 2000; 48: 885–892.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Folstein, MF, Folstein, SE, McHugh, PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.CrossRefGoogle Scholar
Giacino, JT, Whyte, J, Bagiella, E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012; 366: 819–826.CrossRefGoogle ScholarPubMed
Goldman, SA. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Clin Pharmacol Ther 2007; 82: 453–460.CrossRefGoogle ScholarPubMed
Gongvatana, A, Harezlak, J, Buchthal, S, et al. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol 2013; 19: 209–218.CrossRefGoogle ScholarPubMed
Graber, JJ, Sherman, FT, Kaufmann, H, et al. Vitamin B12-responsive severe leukoencephalopathy and autonomic dysfunction in a patient with “normal” serum B12 levels. J Neurol Neurosurg Psychiatry 2010; 81: 1369–1371.CrossRefGoogle Scholar
Graff-Radford, NR. Normal pressure hydrocephalus. Neurol Clin 2007; 25: 809–832.CrossRefGoogle ScholarPubMed
Grossman, AW, Broderick, JP. Advances and challenges in treatment and prevention of ischemic stroke. Ann Neurol 2013; 74: 363–372.CrossRefGoogle ScholarPubMed
Gustafson, L, Hagberg, B. Recovery in hydrocephalic dementia after shunt operation. J Neurol Neurosurg Psychiatry 1978; 41: 940–947.CrossRefGoogle ScholarPubMed
Hoogland, ICM, Portegies, P. HIV-associated dementia: prompt response to zidovudine. Neurol Clin Pract 2014; 4: 264–265.CrossRefGoogle ScholarPubMed
Howard, MO, Bowen, SE, Garland, EL, et al. Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 2011; 6: 18–31.Google ScholarPubMed
Jensen, HB, Ravnborg, M, Dalgas, U, Stenager, E. 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Ther Adv Neurol Disord 2014; 7: 97–113.CrossRefGoogle ScholarPubMed
Johansson, BB. Current trends in stroke rehabilitation: a review with focus on brain plasticity. Acta Neurol Scand 2011; 123: 147–159.CrossRefGoogle ScholarPubMed
Keith, S. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Expert Rev Neurother 2009; 9: 9–31.CrossRefGoogle ScholarPubMed
Klassen, BT, Ahlskog, JE. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology 2011; 77: 1119–1125.CrossRefGoogle ScholarPubMed
Kozora, E, Arciniegas, DB, Duggan, E, et al. White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cogn Behav Neurol 2013; 26: 63–72.CrossRefGoogle ScholarPubMed
Krägeloh-Mann, I, Groeschel, S, Kehrer, C, et al. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort. Bone Marrow Transplant 2013; 48: 369–375.CrossRefGoogle ScholarPubMed
Krivit, W, Peters, C, Shapiro, EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999; 12: 167–176.CrossRefGoogle ScholarPubMed
Lang, C, Reiss, C, Mäurer, M. Natalizumab may improve cognition and mood in multiple sclerosis. Eur Neurol 2012; 67: 162–166.CrossRefGoogle ScholarPubMed
Lee, SP, Wu, CS, Hsieh, LC, et al. Efficacy of magnetic resonance diffusion tensor imaging and three-dimensional fiber tractography in the detection of clinical manifestations of central nervous system lupus. Magn Reson Imaging 2014; 32: 598–603.CrossRefGoogle ScholarPubMed
Leinonen, V, Koivisto, AM, Savolainen, S, et al. Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 2012; 38: 72–86.CrossRefGoogle ScholarPubMed
Leone, P, Janson, CG, Bilianuk, L, et al. Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan’s disease. Ann Neurol 2000; 48: 27–38.3.0.CO;2-6>CrossRefGoogle Scholar
Mackey, AP, Whitaker, KJ, Bunge, SA. Experience-dependent plasticity in white matter microstructure: reasoning training alters structural connectivity. Front Neuroanat 2012; 6: 32.CrossRefGoogle ScholarPubMed
Mayberg, HS, Lozano, AM, Voon, V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651–660.CrossRefGoogle ScholarPubMed
McDowell, S, Whyte, J, D’Esposito, M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998; 121: 1155–1164.CrossRefGoogle ScholarPubMed
Meythaler, JM, Brunner, RC, Johnson, A, Novack, TA. Amantadine to improve neurorecovery in traumatic brain injury–associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002; 17: 300–313.CrossRefGoogle ScholarPubMed
Miner, ME. Acetazolamide treatment of progressive hydrocephalus secondary to intraventricular hemorrhage in a preterm infant. Childs Nerv Syst 1986; 2: 105–106.CrossRefGoogle Scholar
Navia, BA, Jordan, BD, Price, RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19: 517–524.CrossRefGoogle ScholarPubMed
Navia, BA, Cho, E-S, Petito, CK, Price, RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19: 525–535.CrossRefGoogle ScholarPubMed
Orchard, PJ, Tolar, J. Transplant outcomes in leukodystrophies. Semin Hematol 2010; 47: 70–78.CrossRefGoogle ScholarPubMed
Pennisi, G, Ferri, R, Cantone, M, et al. A review of transcranial magnetic stimulation in vascular dementia. Dement Geriatr Cogn Disord 2011; 31: 71–80.CrossRefGoogle ScholarPubMed
Pliskin, NH, Hamer, DP, Goldstein, DS, et al. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon βeta-1-b. Neurology 1996; 47: 1463–1468.CrossRefGoogle Scholar
Qureshi, SU, Blanchette, AR, Jawaid, A, Schulz, PE. Reversible leukoencephalopathy due to chronic unintentional exposure to toluene. Can J Neurol Sci 2009; 36: 388–389.CrossRefGoogle ScholarPubMed
Rektorova, I, Megova, S, Bares, M, Rektor, I. Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. J Neurol Sci 2005; 229–230: 157–161.CrossRefGoogle ScholarPubMed
Rimkus, C de M, Andrade, CS, Leite, C da C, et al. Toxic leukoencephalopathies, including drug, medication, environmental, and radiation-induced encephalopathic syndromes. Semin Ultrasound CT MR 2014; 35: 97–117.CrossRefGoogle ScholarPubMed
Riva-Posse, P, Choi, KS, Holtzheimer, PE, et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2014; 76: 963–969.CrossRefGoogle ScholarPubMed
Román, GC, Salloway, S, Black, SE, et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke 2010; 41: 1213–1221.CrossRefGoogle ScholarPubMed
Rosenberg, NL, Spitz, MC, Filley, CM, et al. Central nervous system effects of chronic toluene abuse – clinical, brainstem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988; 10: 489–495.CrossRefGoogle ScholarPubMed
Rudick, RA, Cohen, JA, Weinstock-Guttman, B, et al. Management of multiple sclerosis. N Engl J Med 1997; 337: 1604–1611.CrossRefGoogle ScholarPubMed
Sakai, JT, Mikulich-Gilbertson, SK, Crowley, TJ. Adolescent inhalant use among male patients in treatment for substance and behavior problems: two-year outcome. Am J Drug Alcohol Abuse 2006; 32: 29–40.CrossRefGoogle ScholarPubMed
Siddall, OM. Use of methylphenidate in traumatic brain injury. Ann Pharmacother 2005; 39: 1309–1313.CrossRefGoogle ScholarPubMed
Simon, JH. From enhancing lesions to brain atrophy in relapsing MS. J Neuroimmunol 1999; 98: 7–15.CrossRefGoogle ScholarPubMed
Solders, M, Martin, DA, Andersson, C, et al. Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy. Bone Marrow Transplant 2014; 49: 1046–1051.CrossRefGoogle ScholarPubMed
Stabler, SP. Vitamin B12 deficiency. N Engl J Med 2013; 368: 149–160.CrossRefGoogle ScholarPubMed
Stojsavljević, N, Lević, Z, Drulović, J, Dragutinović, G. A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology 1997; 49: 878–881.CrossRefGoogle Scholar
Stuss, DT, Winocur, G, Robertson, IH, eds. Cognitive neurorehabilitation. 2nd ed. Cambridge: Cambridge University Press, 2008.CrossRefGoogle Scholar
Su, S, Libman, RB, Diamond, A, Sharfstein, S. Infratentorial and supratentorial leukoencephalopathy associated with vitamin B12 deficiency. J Stroke Cerebrovasc Dis 2000; 9: 136–138.CrossRefGoogle ScholarPubMed
Taber, KH, Hurley, RA, Yudofsky, SC. Diagnosis and treatment of neuropsychiatric disorders. Annu Rev Med 2010; 61: 121–133.CrossRefGoogle ScholarPubMed
Takeuchi, H, Sekiguchi, A, Taki, Y, et al. Training of working memory impacts structural connectivity. J Neurosci 2010; 30: 3297–3303.CrossRefGoogle ScholarPubMed
Tang, YY, Lu, Q, Fan, M, et al. Mechanisms of white matter changes induced by meditation. Proc Natl Acad Sci 2012; 109: 10570–10574.CrossRefGoogle ScholarPubMed
Tenovuo, O, Alin, J, Helenius, H. A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury – what it showed and taught? Brain Inj 2009; 23: 548–558.CrossRefGoogle ScholarPubMed
Thurnher, MM, Schindler, EG, Thurnher, SA, et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR 2000; 21: 670–678.Google ScholarPubMed
Tomimoto, H, Ohtani, R, Shibata, M, Nakamura, N, Ihara, M. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord 2005; 19: 282–288.CrossRefGoogle ScholarPubMed
Tozzi, V, Narciso, P, Galgani, S, et al. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex. AIDS 1993; 7: 683–692.CrossRefGoogle ScholarPubMed
Tran, KD, Ho, A, Jandial, R. Stem cell transplantation methods. Adv Exp Med Biol 2010; 671: 41–57.CrossRefGoogle ScholarPubMed
Tullberg, M, Hultin, L, Ekholm, S, et al. White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand 2002; 105: 417–426.CrossRefGoogle ScholarPubMed
Tumani, H., Uttner, I. Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis. J Neurol 2007; 254 Suppl 2: II69–II72.CrossRefGoogle ScholarPubMed
Vanderver, A, Tonduti, D, Schiffmann, R, et al. Leukodystrophy overview. In: Pagon, RA, Adam, MP, Ardinger, HH, Wallace, SE, Amemiya, A, Bean, LJH, Bird, TD, Dolan, CR, Fong, CT, Smith, RJH, Stephens, K, eds. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2015. 2014 Feb 6.Google Scholar
Wake, H, Lee, PR, Fields, RD. Control of local protein synthesis and initial events in myelination by action potentials. Science 2011; 333: 1647–1651.CrossRefGoogle ScholarPubMed
Wang, S, Young, KM. White matter plasticity in adulthood. Neuroscience 2014; 276: 148–160.CrossRefGoogle ScholarPubMed
Weinstein, A, Schwid, SI, Schiffer, RB, et al. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999; 56: 319–324.CrossRefGoogle ScholarPubMed
Wilson, RK, Williams, MA. The role of the neurologist in the longitudinal management of normal pressure hydrocephalus. Neurologist 2010; 16: 238–248.CrossRefGoogle ScholarPubMed
Wortzel, HS, Arciniegas, DB. Treatment of post-traumatic cognitive impairments. Curr Treat Options Neurol 2012; 14: 493–508.CrossRefGoogle ScholarPubMed
Xu, J, Cheng, Y, Chai, P, Lu, Z, et al. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging. J Rheumatol 2010; 37: 974–986.CrossRefGoogle ScholarPubMed
Zhang, L, Plotkin, RC, Wang, G, et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 2004; 85: 1050–1055.CrossRefGoogle ScholarPubMed
Zheng, X, Schlaug, G. Structural white matter changes in descending motor tracts correlate with improvements in motor impairment after undergoing a treatment course of tDCS and physical therapy. Front Hum Neurosci 2015; 30: 9. 229.Google Scholar
Zhornitsky, S, Wee Yong, V, Koch, MW, et al. Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. CNS Neurosci Ther 2013; 19: 737–744.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Treatment
  • Christopher M. Filley
  • Book: White Matter Dementia
  • Online publication: 05 May 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781139548878.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Treatment
  • Christopher M. Filley
  • Book: White Matter Dementia
  • Online publication: 05 May 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781139548878.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Treatment
  • Christopher M. Filley
  • Book: White Matter Dementia
  • Online publication: 05 May 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781139548878.013
Available formats
×